468 related articles for article (PubMed ID: 2820634)
1. Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: evidence for a decreased lymphokine-induced activity of effector cells.
Hirofuji H; Kakumu S; Fuji A; Ohtani Y; Murase K; Tahara H
Clin Exp Immunol; 1987 May; 68(2):348-56. PubMed ID: 2820634
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic expression of natural killer cell associated membrane antigens in patients with chronic liver disease and hepatocellular carcinoma.
Kakumu S; Hirofuji H; Fuji A; Tahara H; Yoshioka K
J Clin Lab Immunol; 1988 May; 26(1):29-32. PubMed ID: 2846843
[TBL] [Abstract][Full Text] [Related]
3. Depressed lymphokine-activated killer activity and analysis of the precursor cells in peripheral blood of patients with hepatocellular carcinoma.
Shirai M; Watanabe S; Nishioka M
Hepatogastroenterology; 1990 Oct; 37(5):465-8. PubMed ID: 2174825
[TBL] [Abstract][Full Text] [Related]
4. Lysis of human solid tumor cells by lymphokine-activated natural killer cells.
Itoh K; Tilden AB; Balch CM
J Immunol; 1986 May; 136(10):3910-5. PubMed ID: 3084648
[TBL] [Abstract][Full Text] [Related]
5. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
[TBL] [Abstract][Full Text] [Related]
6. [Spontaneous and interferon-induced activity of natural killer cells in patients with liver cirrhosis and chronic active hepatitis].
Müller C; Zielinski CC
Acta Med Austriaca; 1987; 14(5):115-8. PubMed ID: 3125713
[TBL] [Abstract][Full Text] [Related]
7. Relationship between natural killer activity and development of hepatocellular carcinoma in patients with cirrhosis of the liver.
Nakajima T; Mizushima N; Kanai K
Jpn J Clin Oncol; 1987 Dec; 17(4):327-32. PubMed ID: 2826847
[TBL] [Abstract][Full Text] [Related]
8. Alterations in tumor necrosis factor-alpha, interferon-gamma, and interleukin-6 production by natural killer cell-enriched peripheral blood mononuclear cells in chronic alcoholism: relationship with liver disease and ethanol intake.
Laso FJ; Lapeña P; Madruga JI; San Miguel JF; Orfao A; Iglesias MC; Alvarez-Mon M
Alcohol Clin Exp Res; 1997 Oct; 21(7):1226-31. PubMed ID: 9347083
[TBL] [Abstract][Full Text] [Related]
9. Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans.
Ishiyama K; Ohdan H; Ohira M; Mitsuta H; Arihiro K; Asahara T
Hepatology; 2006 Feb; 43(2):362-72. PubMed ID: 16440347
[TBL] [Abstract][Full Text] [Related]
10. Mode of in vitro augmentation of natural killer cell activity by recombinant human interleukin 2: a comparative study of Leu-11+ and Leu-11- cell populations in cord blood and adult peripheral blood.
Seki H; Ueno Y; Taga K; Matsuda A; Miyawaki T; Taniguchi N
J Immunol; 1985 Oct; 135(4):2351-6. PubMed ID: 3928745
[TBL] [Abstract][Full Text] [Related]
11. [Natural killer cell activity of the peripheral blood in patients with hepatocellular carcinoma].
Lin ZY; Weng HZ; Tang ZY; Wang QD
Zhonghua Zhong Liu Za Zhi; 1986 Nov; 8(6):417-20. PubMed ID: 2438105
[TBL] [Abstract][Full Text] [Related]
12. Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure.
Golden-Mason L; Madrigal-Estebas L; McGrath E; Conroy MJ; Ryan EJ; Hegarty JE; O'Farrelly C; Doherty DG
Gut; 2008 Aug; 57(8):1121-8. PubMed ID: 18372499
[TBL] [Abstract][Full Text] [Related]
13. [Hepatocarcinoma and killer cell activity].
Lucea D; Vargas V; Español T; Castells L; Sauleda S; Esteban R; Guardia J
Med Clin (Barc); 1995 Sep; 105(10):370-3. PubMed ID: 7475439
[TBL] [Abstract][Full Text] [Related]
14. Assessment of lymphokine-activated killer activity and gamma-interferon production in patients with small hepatocellular carcinomas.
Saibara T; Maeda T; Miyazaki M; Onishi S; Yamamoto Y
Hepatology; 1993 May; 17(5):781-7. PubMed ID: 7684018
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of interleukin-12-induced interferon-y production in vitro by peripheral blood mononuclear cells in patients with chronic liver disease.
Imanishi H; Cheng J; Ikeda N; Saito M; Ohno M; Hara N; Shimomura S; Yamamoto T; Amuro Y; Fujiwara H; Hada T
Hepatogastroenterology; 2003; 50(53):1502-5. PubMed ID: 14571773
[TBL] [Abstract][Full Text] [Related]
16. Lymphokine-activated and natural killer cell activity in human intestinal mucosa.
Hogan PG; Hapel AJ; Doe WF
J Immunol; 1985 Sep; 135(3):1731-8. PubMed ID: 3926882
[TBL] [Abstract][Full Text] [Related]
17. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
Muralikrishna K; Varalakshmi C; Khar A
Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
[TBL] [Abstract][Full Text] [Related]
18. Decreased natural killer cytotoxic activity in chronic alcoholism is associated with alcohol liver disease but not active ethanol consumption.
Laso FJ; Madruga JI; Girón JA; López A; Ciudad J; San Miguel JF; Alvarez-Mon M; Orfao A
Hepatology; 1997 May; 25(5):1096-100. PubMed ID: 9141423
[TBL] [Abstract][Full Text] [Related]
19. Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL 2) in collaboration with interferon-gamma (IFN-gamma).
Itoh K; Shiiba K; Shimizu Y; Suzuki R; Kumagai K
J Immunol; 1985 May; 134(5):3124-9. PubMed ID: 2984283
[TBL] [Abstract][Full Text] [Related]
20. Ultrastructural and functional effects of lipopolysaccharide and interleukin-2 on human NK cells.
Kang YH; Carl M; Watson LP
Scanning Microsc; 1988 Sep; 2(3):1567-86. PubMed ID: 3059478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
